Sun Pharma Q3 net profit rises 16.5 per cent to Rs 2,523.8 crore; announces interim dividend
It had posted a consolidated net profit of Rs 2,166 crore in the year-ago period
Stay updated with breaking news from Sun Pharma Results. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
It had posted a consolidated net profit of Rs 2,166 crore in the year-ago period
Operating profit, calculated as earnings before interest, taxes, depreciation, and amortization (EBITDA), for the quarter, rose nearly 8% on year to Rs 3,179.30 crore, but operating margin contracted by 91 basis points to 26.08%. Total expenses in the quarter rose to Rs 9,695 crore, from Rs 8,625 crore a year ago.
The company also said that the full effect of national list of essential medicines (NLEM) is visible in this quarter.
The fall in the bottomline was partly due to certain one-time charges totalling Rs 323 crore. The company also incurred a one-time transitional cost of Rs 51 crore on the relocation of Alchemee operations from California to New York.
Sun Pharma Q1 results: Revenue jumps 11% at Rs 11,941 cr